• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

News of the day

PR Newswire search

Most viewed

Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission

Roche Diagnostics Expands Availability of HCV Immunoassay

Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate

European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients

Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Development

More recent news

ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
30th September 2008 OR AKIVA, Israel, September 30 /PRNewswire/ -- ITGI Medical, Ltd. (TASE: ITGI) a company engaged with research, development, manufacturing and marketing of heterologous tissue covered stents,...

Sun Pharmaceutical Announces USFDA Approval to Market Generic Paraplatin(R) Injection
23rd September 2008 MUMBAI, India, September 23 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. announced that USFDA has granted an approval for the Abbreviated New Drug Application (ANDA) to market...

AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease with AMT's Proprietary Gene Therapy Platform
18th September 2008 AMSTERDAM, The Netherlands, September 18 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a license from...

Ekkyo Continues its Development With the CE Marking of EkkyLite(R)
16th September 2008 MARSEILLES, France, September 16 /PRNewswire/ -- Ekkyo a photomedicine company, which develops first-in-class laser-based systems for skin scar prevention and reduction, announces that EkkyLite(R) a...

Glucophage(R) Powder for Oral Solution in Sachet Receives Positive Opinion for Approval in Europe
10th September 2008 GENEVA, Switzerland, September 10 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Glucophage(R) Powder for Oral Solution in Sachet (metformin...

GNC Continues European Expansion Through Exclusive Online Distribution Agreement with Active Nutrition International for Sales of Sports Nutrition Products in Sweden, Finland, Denmark & Norway
3rd September 2008 PITTSBURGH, September 3 /PRNewswire/ -- General Nutrition Centers, Inc., the largest global specialty retailer of nutritional supplements, today announced another step in its continuing expansion in...

Bavarian Nordic Announces Partnership With National Cancer Institute in the US and Obtains Rights to a New Vaccine Candidate
13th August 2008 KVISTGARD, Denmark, August 13 /PRNewswire/ -- Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics has entered into a scientific partnership with the National Cancer Institute (NCI) in the...

Bavarian Nordic Announces Partnership With National Cancer Institute in the US and Obtains Rights to a New Vaccine Candidate
13th August 2008 KVISTGARD, Denmark, August 13 /PRNewswire/ -- Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics has entered into a scientific partnership with the National Cancer Institute (NCI) in the...

Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
12th August 2008 MOUNTAIN VIEW, California, August 12 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, announced today that it has entered into...

Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
12th August 2008 MOUNTAIN VIEW, California, August 12 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, announced today that it has entered into...

ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
5th August 2008 HALIFAX, Canada, August 5 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, today announced receipt of patent approval from the Japanese Patent Office for its...

Cytochroma and Mitsubishi Tanabe Form Partnership for Chronic Kidney Disease Therapies in U.S. and Asia
30th July 2008 MARKHAM, Canada and OSAKA, Japan, July 30 /PRNewswire/ -- Cytochroma and Mitsubishi Tanabe Pharma Corporation ("MTPC") today announced that the companies have signed a license agreement under which...

Max Planck Society Awards Exclusive License to Dafra Pharma R&D to Develop a Drug Against Leishmaniasis
16th July 2008 TURNHOUT, Belgium, July 16 /PRNewswire/ -- Max Planck Innovation, the technology transfer agency of the Max Planck Society based in Munich, Germany and Dafra Pharma R&D, a Belgian research company...

BioWa and Medarex Announce License of BioWa's COMPLEGENT(TM) Technology
16th July 2008 PRINCETON, New Jersey, July 16 /PRNewswire/ -- BioWa, Inc. and Medarex, Inc. (Nasdaq: MEDX) announced today that they have entered into a license agreement which provides Medarex with the first ever...

Jerini Receives European Commission Approval for FIRAZYR(R) (Icatibant) in the Treatment of HAE
15th July 2008 BASINGSTOKE, England and CAMBRIDGE, Massachusetts, July 15 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, notes that Jerini AG (FSE:JI4) has...

RiderSaver(TM) EMF Seat Shield Reduces Motorcycle Cancer Concern
11th July 2008 MISSISSAUGA, Ontario, July 11 /PRNewswire/ -- A new motorcycle seat accessory provides peace of mind for riders concerned about cancer risk. "It's not just about cancer," says Canadian author and...

Pinnacle Biologics Announces Agreement With pharmexx to Expand Sales Support Activities in Key European Markets
10th July 2008 BANNOCKBURN, Illinois, July 10 /PRNewswire/ -- Pinnacle Biologics, a private, full-service pharmaceutical and biotech solutions company today announced it has entered into an agreement with pharmexx...

European Commission Announces Marketing Authorisation for 50mg Once Weekly Enbrel(R) for Patients With Moderate-to-Severe Psoriasis
9th July 2008 MAIDENHEAD, England, July 9 /PRNewswire/ -- The European Commission announced today a new 50 mg Enbrel(R) (etanercept) once weekly dosage regimen as an alternative to the currently approved 25 mg...

European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients
7th July 2008 MAIDENHEAD, England, July 7 /PRNewswire/ -- Wyeth Pharmaceuticals, today 3rd July, announced that it has received EMEA marketing approval for Relistor(TM) (methylnaltrexone bromide) subcutaneous...

Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited
3rd July 2008 NAPA, California, July 3 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

MS Drug Development Agreement Based on WEHI's Medicinal Chemistry
2nd July 2008 MELBOURNE, Australia, July 2 /PRNewswire/ -- Research conducted at The Walter and Eliza Hall Institute (WEHI) has contributed significantly to a major licensing agreement signed between Australian...

Eastern European Supplement Leader Walmark Launches Prenatal Product Featuring Martek's life'sDHA(TM)
26th June 2008 COLUMBIA, Maryland, June 26 /PRNewswire/ -- Martek Biosciences (Nasdaq: MATK) announced today that life'sDHA(TM), its patented, vegetarian form of DHA-omega 3 essential for infant brain and...

NICE Issues Final Appraisal Determination (FAD) Which Recommends Baraclude(R) (Entecavir) as a Treatment Option for Eligible Chronic Hepatitis B Patients
24th June 2008 UXBRIDGE, England, June 25 /PRNewswire/ -- NICE (National Institute for Health and Clinical Excellence) has announced today, in its Final Appraisal Determination (FAD), that Baraclude(R) (entecavir)...

Pinnacle Biologics Announces Contract With Chiltern
24th June 2008 ROCKVILLE, Maryland, June 24 /PRNewswire/ -- Pinnacle Biologics, a private, full-service pharmaceutical and biotech solutions company, today announced it has entered into an agreement with Chiltern...

Cardium's InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
19th June 2008 SAN DIEGO, June 19 /PRNewswire/ -- Cardium Therapeutics (Amex: CXM) and its operating unit InnerCool Therapies announced today that InnerCool has entered into a exclusive commercialization agreement...

Merck Serono and Bionomics Announce Multiple Sclerosis Development and Licensing Agreement
18th June 2008 GENEVA, June 18 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that a Development and Licensing Agreement with Bionomics (ASX: BNO) was signed, under...

ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
18th June 2008 LEUVEN, Belgium, LUND, Sweden and BASEL, Switzerland, June 18 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (Nordic Exchange: BINV) announce that they have...

Pinnacle Biologics Announces Logistics Services Agreement With the Movianto Group
17th June 2008 ROCKVILLE, Maryland, June 17 /PRNewswire/ -- Pinnacle Biologics, a private, full-service pharmaceutical and biotech solutions company, today announced it has entered into a logistic service agreement...

BioWa Licenses POTELLIGENT(R) Technology to Major Pharmaceutical Company for Use in Antibody Research and Development
11th June 2008 PRINCETON, New Jersey, June 11 /PRNewswire/ -- BioWa, Inc. announced today that it has licensed its POTELLIGENT(R) Technology to Novartis for the development of antibody therapeutics with enhanced...

AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy
22nd May 2008 AMSTERDAM, The Netherlands, May 22 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a license from La...

Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
19th May 2008 NEW YORK, May 19 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment...

Senetek PLC Reports First Quarter 2008 Financial Results
15th May 2008 NAPA, California, May 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare
7th May 2008 SAN FRANCISCO and NEW YORK, May 7 /PRNewswire/ -- NGN Capital announced today the formation of ACT Biotech Inc., a new company dedicated to developing and commercializing targeted oral cancer drugs....

Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug
7th May 2008 TORONTO, May 7 /PRNewswire/ -- Apotex Inc., Canada's largest generic pharmaceutical company has successfully bid and been awarded a tender from the Rwandan Government for the life saving triple...

Astellas' Mycamine(R) (micafungin) Licensed for Use in Europe to Treat Serious Fungal Infections
7th May 2008 STAINES, England, May 7 /PRNewswire/ -- The European Medicines Agency (EMEA) has announced the marketing authorisation of Mycamine(R), Astellas Pharma Europe's treatment for invasive candidiasis,...

Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Development
6th May 2008 TORONTO, May 6 /PRNewswire/ -- Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider, and Thermo Fisher Scientific have entered into an agreement under which Dalton will...

Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
28th April 2008 REHOVOT, Israel and JERSEY CITY, New Jersey, April 28 /PRNewswire/ -- Rosetta Genomics (Nasdaq:ROSG), a leading developer of microRNA-based diagnostics and therapeutics, announced today that it...

Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System
22nd April 2008 ABBOTT PARK, Illinois and ST. PAUL, Minnesota, April 22 /PRNewswire/ -- Smiths Medical MD will promote and distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System...

CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label
17th April 2008 ATLANTA, April 17 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that it has signed an exclusive three-year agreement with...

Senetek PLC Announces Riley-Nacht LLC - Leading Global Brand Development Company to Direct Dermatological Product Marketing Program
17th April 2008 NAPA, California, April 17 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation
16th April 2008 RALEIGH, North Carolina, April 16 /PRNewswire/ -- DARA BioSciences(TM) (Nasdaq: DARA) announced today that Surgi-Vision, Inc., a privately held company of which DARA Biosciences owns...

Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
15th April 2008 AMSTERDAM, April 15 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announced today that the U.S. Food and Drug Administration (FDA) has granted its product Rhitol(TM) Orphan Drug Designation...

Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis
15th April 2008 REDWOOD CITY, California, April 15 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, and Pfizer Pharmaceuticals, Inc. (NYSE: PFE),...